- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05169138
The Effect Of Lavender Essential Oil On Birth Pain
The Effect Of Lavender Essential Oil And Inhalation And Massage Methods On Birth Pain İn Primiparous Women
Study Overview
Status
Conditions
Detailed Description
In universe of the research; Pregnant women who applied to Adana Seyhan State Hospital's Marsa Gynecology and Obstetrics Additional Service Building and Obstetrics Service and Delivery Room between the dates of the study, accepted to participate in the study voluntarily and who met the research conditions included. Numbers 1-2 of a 6-sided dice determined by the dice rolling system formed the control group (40 pregnant), numbers 3-4 were lavender oil inhalation group (44 pregnant), and numbers 5-6 were lavender oil massage group (37 pregnant).
The research was carried out in three stages for the experimental groups and control groups. First stage; Informed Voluntary Consent Form and Questionnaire were applied to the pregnant women whose groups were determined by the chosen randomization method. Afterwards, for the experimental groups according to the group; 10-minute training sessions were given on the inhalation method or massage method with aromatic lavender essential oil. In the second stage; Data were recorded by dividing the first phase of labor into 3 phases for each group. Visual Analog Pain Scale and McGill Melzack Pain Questionnaire were applied to the experimental groups 6 times, before and 30 minutes after the application. At this stage, no application was made in the control group, the Visual Analog Pain Scales and McGill Melzack Pain Questionnaire were applied at the beginning of each phase, the same forms were repeated after 30 minutes and the data were recorded 6 times in total. In the third stage; In the postpartum period, the study was completed by applying the Postpartum Period Information Collection Form by face-to-face interviews with the experimental groups and the pregnant women in the control group.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nicosia, Cyprus
- Near East University / Turkish Republic of Northern Cyprus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
INCLUSİON CRİTERİA:
- Single pregnancy
- Primiparous gestational age more than 36 weeks (term)
- Cervical dilatation of at least 3 cm
- Pregnants with 3 uterine contractions in a 10-minute period lasting at least 30 seconds
- Cephalic presentation
- Not receiving analgesics, sedatives or anesthetics during labor,
- Not using induction at birth
EXCLUSİON CRİTERİA:
- Multiparity
- cephalopelvic incompatibility
- third trimester bleeding history
- intrauterine growth retardation
- multiple pregnancy
- breech presentation
- subject's withdrawal from clinical trial
- allergy to aromatic lavender essential oil
- addiction (alcohol, smoking)
- obstetric conditions requiring emergency cesarean section
- infertility history
- previous history of diagnosis of an underlying disease
- induction at birth
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: massage group with lavender essential oil
Pregnant women (n:37) who participated in this group were given an intense massage for at least 10 minutes in each phase during the first phase of labor.
Visual Analog Pain Scale and McGill Melzack Pain Questionnaire were applied before and after the application, and the process was completed with a total of 6 measurements.
|
The application was applied to 37 pregnant women in total, and the effect of massage with lavender oil on labor pain was investigated.
|
|
Placebo Comparator: group of inhalations with lavender essential oil
Pregnant women (n:44) who participated in this group were administered inhalation with lavender oil at an intensity of at least 10 minutes in each phase during the first phase of labor.
Visual Analog Pain Scale and McGill Melzack Pain Questionnaire were applied before and after the application, and the process was completed with a total of 6 measurements.
|
The application was applied to 41 pregnant women in total, and the effect of inhalation with lavender oil on labor pain was investigated.
|
|
No Intervention: control group
No application was made to the pregnant women (n:40) who participated in this group in each phase of the first phase of labor.
Despite this, the Visual Analog Pain Scale and McGill Melzack Pain Questionnaire, which were applied at the beginning of each phase in order to increase the reliability of the results, were re-evaluated 30 minutes after the measurements, even though there was no application, and the process was completed with a total of 6 measurements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale
Time Frame: through study completion, an average of 9 month
|
It is used to convert some values that cannot be measured numerically into numeric.
Two extreme values of the parameter to be evaluated are written at the two ends of a 10 cm line, and the patient is asked to determine where his/her condition is appropriate on this line by drawing a line, putting a dot or placing any sign.
For pain; "I have no pain" is written on one end and "very severe pain" is written on the other end and the patient is asked to mark the current situation on the line.
The minimum score from the scale is 0, and the maximum score is 10.
According to the scale, the highest pain value is expressed with 10 points, while 0 defines the least pain.
|
through study completion, an average of 9 month
|
|
McGill Melzack Pain Questionnaire
Time Frame: through study completion, an average of 9 month
|
It is a multidimensional pain assessment tool consisting of four parts. At the entrance of the form, personal information of the patient, medical diagnosis-problem, introductory information to determine the location, characteristics, relationship and severity of pain according to the patient's perception are included. In the McGill Melzack pain questionnaire, the lowest score is 0 and the highest score is 112. 0 denotes the least pain level and the least pain-related discomfort, while 112 denotes the most severe pain and the most pain-related discomfort. |
through study completion, an average of 9 month
|
|
Questionnaire
Time Frame: through study completion, an average of 9 month
|
It was developed by the researcher as a result of literature review and includes 30 questions in total.
It was aimed to collect information about the sociodemographic and obstetric anamnesis of pregnant women through the form.
|
through study completion, an average of 9 month
|
|
Postpartum Period Data Collection Form
Time Frame: through study completion, an average of 9 month
|
It was developed by the researcher as a result of literature review and includes 21 questions in total.
Via the form; It is aimed to collect information on labor, newborn characteristics, postpartum mother and baby interaction, and evaluation of mothers' satisfaction with massage or inhalation methods.
|
through study completion, an average of 9 month
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Filiz Yarıcı, Study Director
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021/1367
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor Pain
-
Antalya Bilim UniversityCompletedChildbirth | Normal Labor | Labor Pain and to Reduce PainTurkey (Türkiye)
-
Pınar ErdoğanCompletedLabor Progress | Labor Pain and AnxietyTurkey (Türkiye)
-
Soovu Labs Inc.Virginia Mason Hospital/Medical CenterNot yet recruiting
-
Bogomolets National Medical UniversityCompleted
-
Cairo UniversityNot yet recruiting
-
Martin-Luther-Universität Halle-WittenbergCompleted
-
Maimonides Medical CenterTerminated
-
Roi TreisterHillel Yaffe Medical CenterNot yet recruitingLabor Pain and to Reduce PainIsrael
-
Aretaieio HospitalRecruitingLabor Pain | Pain, Labor | EpiduralGreece
Clinical Trials on Aromatherapy application /massage with lavender oil
-
University of BaghdadNot yet recruitingRheumatoid Arthritis (RA)
-
TC Erciyes UniversityThe Scientific and Technological Research Council of TurkeyCompleted
-
Tokat Gaziosmanpasa UniversityCompleted
-
San Gallicano Dermatological Institute IRCCSCompletedMelanoma | Preoperative Anxiety | Non-Melanoma Skin Cancer | pT1aItaly
-
Goknur Demir HacimusalarCompletedHemodialysis PatientsTurkey (Türkiye)
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingChronic Heart Failure
-
TC Erciyes UniversityCompleted
-
University of Sao PauloActive, not recruitingLabor Pain and AnxietyBrazil
-
Afide TufanActive, not recruitingCystoscopy | Aromatherapy | Hand MassageTurkey
-
City of Hope Medical CenterNational Cancer Institute (NCI)SuspendedMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States